FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2768470642> ?p ?o ?g. }

• W2768470642 abstract "2549 Background: Dose-banding has been recently suggested in order to optimize chemotherapy preparation. Ranges (or bands) of body surface area (BSA) are predefined. The individual dose of a particular patient is calculated according to a single BSA value per band, usually the mid-point of the BSA band in which the actual BSA of the patient lies. Thanks to this simple procedure, chemotherapy provision can be rationalized and chemotherapies can be prepared in advance for drugs with sufficient long-term drug stability. The primary purpose of dose-banding is to reduce patient waiting time and improve capacity planning of the pharmacy production, but additional benefits can also be found, such as reduced potential for medication errors, reduced drug wastage, and prospective quality control of preparations. The objective of this analysis was to compare dose-banding to individual BSA-dosing (current practice) according to pharmacokinetic (PK) criteria. Methods: Dose-banding was defined according to three bands of BSA: BSA<1.7m², 1.7m²≤BSA<1.9m², and BSA≥1.9m² for which the values of 1.55m², 1.80m², and 2.05m² were allocated, respectively. By using individual actual values of clearance of six drugs (cisplatin, docetaxel, paclitaxel, doxorubicin, topotecan, and irinotecan) from a total of 1,206 adult cancer patients, the AUCs corresponding to the two dosing methods were compared to a target value of AUC for each drug. Results: Over all 6 drugs, by using dose-banding the percent change of individual dose in comparison with BSA dosing ranged between -14% and +22%. In terms of capacity to attain the target AUC, there was no significant difference in precision when using dose-banding as compared to BSA-dosing for all drugs except paclitaxel (precision of 23.2% versus 21.8%, respectively). For all drugs including paclitaxel, distributions of AUC values were very similar with both dosing methods. Conclusions: For these 6 drugs and maybe others, dose-banding may be implemented without any risk of increasing interindividual plasma exposure. Dose-banding would make it possible to anticipate chemotherapy preparation and analytical control without any delay for the patients." @default.
• W2768470642 created "2017-12-04" @default.
• W2768470642 creator A5012501491 @default.
• W2768470642 creator A5058431359 @default.
• W2768470642 creator A5065279964 @default.
• W2768470642 creator A5074174053 @default.
• W2768470642 creator A5077260725 @default.
• W2768470642 date "2012-05-20" @default.
• W2768470642 modified "2023-09-27" @default.
• W2768470642 title "Recommendation of dose banding of cytotoxics according to pharmacokinetic criteria." @default.
• W2768470642 doi "https://doi.org/10.1200/jco.2012.30.15_suppl.2549" @default.
• W2768470642 hasPublicationYear "2012" @default.
• W2768470642 type Work @default.
• W2768470642 sameAs 2768470642 @default.
• W2768470642 citedByCount "0" @default.
• W2768470642 crossrefType "journal-article" @default.
• W2768470642 hasAuthorship W2768470642A5012501491 @default.
• W2768470642 hasAuthorship W2768470642A5058431359 @default.
• W2768470642 hasAuthorship W2768470642A5065279964 @default.
• W2768470642 hasAuthorship W2768470642A5074174053 @default.
• W2768470642 hasAuthorship W2768470642A5077260725 @default.
• W2768470642 hasConcept C112705442 @default.
• W2768470642 hasConcept C126322002 @default.
• W2768470642 hasConcept C2776694085 @default.
• W2768470642 hasConcept C2777288759 @default.
• W2768470642 hasConcept C2777501473 @default.
• W2768470642 hasConcept C2780035454 @default.
• W2768470642 hasConcept C71924100 @default.
• W2768470642 hasConcept C98274493 @default.
• W2768470642 hasConceptScore W2768470642C112705442 @default.
• W2768470642 hasConceptScore W2768470642C126322002 @default.
• W2768470642 hasConceptScore W2768470642C2776694085 @default.
• W2768470642 hasConceptScore W2768470642C2777288759 @default.
• W2768470642 hasConceptScore W2768470642C2777501473 @default.
• W2768470642 hasConceptScore W2768470642C2780035454 @default.
• W2768470642 hasConceptScore W2768470642C71924100 @default.
• W2768470642 hasConceptScore W2768470642C98274493 @default.
• W2768470642 hasLocation W27684706421 @default.
• W2768470642 hasOpenAccess W2768470642 @default.
• W2768470642 hasPrimaryLocation W27684706421 @default.
• W2768470642 hasRelatedWork W1519479496 @default.
• W2768470642 hasRelatedWork W1876366940 @default.
• W2768470642 hasRelatedWork W1964467003 @default.
• W2768470642 hasRelatedWork W1986253871 @default.
• W2768470642 hasRelatedWork W1995540899 @default.
• W2768470642 hasRelatedWork W2002393038 @default.
• W2768470642 hasRelatedWork W2009809271 @default.
• W2768470642 hasRelatedWork W2031293549 @default.
• W2768470642 hasRelatedWork W2067410764 @default.
• W2768470642 hasRelatedWork W2156675827 @default.
• W2768470642 hasRelatedWork W2417187835 @default.
• W2768470642 hasRelatedWork W2590308184 @default.
• W2768470642 hasRelatedWork W2782818491 @default.
• W2768470642 hasRelatedWork W2793882054 @default.
• W2768470642 hasRelatedWork W2946084613 @default.
• W2768470642 hasRelatedWork W2946568743 @default.
• W2768470642 hasRelatedWork W2981852780 @default.
• W2768470642 hasRelatedWork W6045869 @default.
• W2768470642 hasRelatedWork W95423466 @default.
• W2768470642 hasRelatedWork W3117508151 @default.
• W2768470642 isParatext "false" @default.
• W2768470642 isRetracted "false" @default.
• W2768470642 magId "2768470642" @default.
• W2768470642 workType "article" @default.